Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Pharmacies trying to profiteer from pandemic will face action, regulators warn

Any pharmacy or pharmacy owner found to have breached competition or consumer protection law risks facing action for damaging public confidence, the pharmacy regulator has warned.

The General Pharmaceutical Council (GPhC) and the Competition and Markets Authority (CMA) have written a joint letter to superintendent pharmacists and pharmacy contractors asking them to ensure they do not damage public confidence.


The letter said that “a small minority of pharmacies are seeking to benefit from the coronavirus pandemic by charging unjustifiably high prices for essential products – including hand sanitiser, face masks and paracetamol – which continue to be in very high demand.”

“Whilst the numbers involved may be small, the issue has been prominent in the public eye,” the letter added.

The pharmacy regulator said it was engaging with the CMA to ensure that the two bodies could use their “respective roles and powers in a complementary and proportionate way” while dealing with complaints about extortionate pricing.

The GPhC clarified that while it usually doesn't take action on matters that are purely commercial in nature and have no medicinal or practice-related element, this was a broader issue that would impact on public confidence.

As the country’s lead competition and consumer authority, the CMA said it was concerned about any price charged by a pharmacy for an essential product that is higher than the ‘normal’ price as a result of percentage mark-up on the wholesale price it has paid.

It had recently announced the launch of an investigation against four convenience stores and pharmacies over suspected excessive and unfair pricing of hand sanitiser products during the Covid-19 pandemic.

The letter stated that consequences of the CMA reaching a final finding that competition law has been infringed are potentially significant and include the possibility of financial penalties.

Pharmacies experiencing large price rises or other unfair practices from their suppliers have been asked to report this to the CMA by using its online complaints form.

More For You

NHS to invest millions to boost enhanced treatment for sickle cell patients

Approximately 17,000 people live in England with sickle cell disease

Pic credit: istock

NHS to invest millions to boost enhanced treatment for sickle cell patients

The Department of Health and Social Care has announced that it will invest £9 million towards the treatment of sickle cell patients.

Approximately 17,000 people live in England with sickle cell disease. Nearly 250 new cases of this inherited blood disorder is reported annually.

Keep ReadingShow less
NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients

An estimated 6,000 cases of multiple myeloma is diagnosed in the UK each year.

Pic credit: istock

NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients


NHS England has become the first in the world to introduce a ‘trojan horse’ therapy for the victims of blood cancer with the ground-breaking treatment slowing down the illness three-times more than existing treatments.

Keep ReadingShow less
Call to improve inclusivity in clinical research

Ethnic minority adults continue to be underrepresented in clinical trials.

iStock

Call to improve inclusivity in clinical research

A NEW report has called for the participation of a wide range of diverse communities in clinical research to make sure that the medicines meet the needs of the UK's increasingly diverse population.

The report ‘Achieving inclusivity in clinical research’, prepared by the Association of the British Pharmaceutical Industry (ABPI) and the Association of Medical Research Charities (AMRC), highlights the long-standing challenges in ensuring diversity in clinical trials.

Keep ReadingShow less
Pharmacy students Learning Support Fund

Pharmacy students will be included in the Travel and Dual Accommodation Expenses section of the NHS Learning Support Fund.

iStock

Pharmacy students to have access to Learning Support Fund

FOR the first time in England, pharmacy students will be eligible to reimburse travel and accommodation costs while attending placements.

The Department of Health and Social Care confirmed that pharmacy students would finally be included in the Travel and Dual Accommodation Expenses (TDAE) section of the NHS Learning Support Fund (LSF).

Keep ReadingShow less
NHS for robotic surgery

Patients undergoing robotic surgery are able to recover quicker and be discharged sooner.

Pic credit: iStock

NHS pushes for robotic surgery to reduce waiting time, improve outcomes

The NHS is planning to step up robotic surgery over the next decade to reduce waiting time, help in the speed of recovery of patients, and shorter hospital stay.

As per the NHS projections, the number is expected to zoom from 70,000 in 2023/24 to half a million by 2035.

Keep ReadingShow less